Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

SG&A

Share-based compensation expense

Asset impairment and restructuring costs

Expected credit losses on financial assets and related charges

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Canopy Growth

Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

Revenue

Cost of revenue

Gross profit

Operating expenses

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Canopy Growth Corp. engages in the production, distribution, and sale of cannabis and cannabinoid-based products for both adult-use and medical purposes. The firm operates through the following segments: Canada Cannabis, Rest-of-world Cannabis, Storz and Bickel, BioSteel, This Works, and Other. The Canada Cannabis segment includes the production, distribution, and sale of cannabis, hemp, and cannabis products in Canada. The Rest-of-world Cannabis segment focuses on production and sale of cannabis, hemp, and cannabis products internationally. The Storz and Bickel segment produces and sells vaporizers. The BioSteel segment refers to the sale of consumer packaged goods including sports nutrition beverages, hydration mixes, proteins, and other specialty nutrition products. The This Works segment includes the production and sale of beauty, skincare, wellness, and sleep products, some of which have been blended with hemp-derived CBD isolate. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Canopy Growth's hopes hinge on federal marijuana legalization in the U.S. Federal legalization could still be years away, and there's no guarantee that it ever will happen. Canopy Growth continues to burn cash at a high rate.

Down 98% in 5 Years, Is There Any Hope Canopy Growth Stock Can Ever Recover?

SMITHS FALLS, ON , Oct. 26, 2023 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NASDAQ: CGC) will release its financial results for the second quarter fiscal year 2024 ended September 30, 2023 after markets close on November 9, 2023. Following the release of its second quarter fiscal year 2024 financial results, Canopy Growth will host an audio webcast with David Klein, CEO and Judy Hong, CFO on November 9, at 5:30 PM Eastern Time.

Canopy Growth to Report Second Quarter Fiscal 2024 Financial Results on November 9, 2023

In the second quarter of fiscal 2024, Canopy Growth (CGS) is expected to demonstrate an improved performance in the Canadian cannabis business.

What's in Store for Canopy Growth (CGC) in Q2 Earnings?

Cronos Group

SNDL Inc.

Investors and traders in the Canadian cannabis market are closely monitoring the leading Canadian cannabis stocks as November draws near. Recent years have seen a substantial increase in the legalization of cannabis and a shift in public perception of the plant as a whole. New Frontier Data estimated that the global legal cannabis business was worth $17.5 billion in 2019 and that it would be worth a staggering $105.9 billion by 2025. Due to this rapid expansion and Canada's dominant position in the production and distribution of cannabis, Canadian cannabis stocks are in high demand from both long-term investors and short-term traders.

Stay Ahead of the Game: Canadian Cannabis Stocks to Watch Before November

The current activity in the U.S. House of Representatives doesn't benefit cannabis companies. While the chamber lacks a Speaker, it can't conduct any business -- which includes debating and voting on drug reform measures.

Why Cannabis Stocks Like Canopy Growth and Cresco Labs Plummeted Today

Tilray Brands

As we enter the fourth quarter of 2023 the cannabis sector is progressing into the future. More companies are working on various ventures and developing new products. Not only that there is the continued effort to establish federal cannabis reform more notably the SAFER Banking Act. Due to the current conflict between Israel and Palestine and other political priorities like the 2024 presidential election. So the issue of passing any type of federal reform has once again taken a back seat.

These Marijuana Stocks Could See Better Trading Come 2024

Canopy Growth is at an awkward time when it's both shrinking and waiting to grow. Its parallel organization in the U.S. may be having better luck.

3 Things About Canopy Growth That Smart Investors Know

Aurora Cannabis

HEXO Corp

OrganiGram Holdings Inc.

Tuesday, October 17, 2023 marks five years since recreational cannabis was legalized in Canada and it's been tough going for operators in the budding sector. Industry players have had to contend with oversaturation, competition from the black market, limited opportunities to enter the United States market, and, more recently, challenging broader economic conditions due to high inflation and interest rates.

Cannabis stocks struggle as Canada marks five years of legal recreational use

Green Thumb Industries Inc.

Cannabis stocks have been stagnant or declining due to cash burn and regulatory challenges. Despite this, many bulls have once again begun expecting a resurgence in this sector.

3 Overbought Cannabis Stocks That Are Due for a Reckoning

First-of-its kind vaporizer features adjustable air flow and is the fastest heating vaporizer in the S&B lineup TUTTLINGEN, Germany , Oct. 17, 2023 /PRNewswire/ - STORZ & BICKEL GmbH ("STORZ & BICKEL"), a world-leading manufacturer of high-end and medically certified vaporizers and a subsidiary of Canopy Growth Corporation ("Canopy Growth") (TSX: WEED) (NASDAQ: CGC), today announced the anticipated launch of the VENTY, STORZ & BICKEL's state-of-the-art portable vaporizer for dry herbs. Its newly designed convection and conduction heater as well as the cutting-edge heating management and cooling technology enhance flavor to produce superior vapor quality on the go.

STORZ & BICKEL Unveils the VENTY, an Innovative New Portable Vaporizer

Curaleaf Holdings, Inc.

PayPal

Trulieve Cannabis Corp.

Tesla

The cannabis industry operates in a quasi-legal environment that makes it difficult for companies to grow. The federal ban on pot creates many hurdles for businesses.

Is Elon Musk the Hero the Cannabis Industry Needs Right Now?

Amplify Seymour Cannabis ETF

Grana y Montero

MedMen Enterprises Inc.

AdvisorShares Pure US Cannabis ETF

Roundhill Cannabis ETF

AdvisorShares Pure Cannabis ETF 

Cautious optimism is warranted in the cannabis industry due to potential changes, such as the move to federal legalization and improved fundamentals. Investors should consider their risk appetite, timeframes, and political catalysts when choosing cannabis companies to invest in.

Reasons To Be Cautiously Optimistic About Cannabis

Canopy Growth's cash burn is high but could improve as the company stops funding BioSteel. Dilution, however, may become a much bigger problem for investors in the future.

Will Canopy Growth Run Out of Cash?

Pity the average cannabis stock investor. Since 2021, shares of the largest cannabis fund, the AdvisorShares Pure US Cannabis ETF (NYSEARCA: MSOS ) have lost over 80% of their value.

2 A-Rated Cannabis Stocks Are the ONLY Ones You Should Buy Right Now

Cannabis companies in Canada have been struggling to gain market share. Competition is fierce, and growth rates have deteriorated significantly in recent years.

Canada Legalized Marijuana 5 Years Ago. Why Is the Industry Now in Such Bad Shape?

Canopy Growth Corporation (TSX:WEED, NYSE:CGC) on Tuesday announced that it has received EU GMP certification from RP Tuebingen, Regional Health Inspectorate of Baden-Wuerttemberg for the company's cannabis cultivation facility in Kincardine, Ontario.  The Canadian cannabis and consumer packaged goods (CPG) firm said the certification enables it to continue exporting high quality cannabis to global medical markets while completing the consolidation of its production footprint into two purpose-built sites.

Canopy Growth receives EU GMP certification for its Kincardine facility

Canopy Growth received important European certification for medical marijuana sales. Its shares have been down by more than 25% over the past month.

Why Canopy Growth Stock Spiked Today

Certification Enables Canopy Growth to Continue Exporting High Quality Cannabis to Global Medical Markets SMITHS FALLS, ON , Oct. 10, 2023 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (Nasdaq: CGC) announced today that it received EU GMP certification from RP Tuebingen, Regional Health Inspectorate of Baden-Wuerttemberg for the Company's world class cannabis cultivation facility in Kincardine, Ontario. As a final step to completing the Company's consolidation of its production footprint into two purpose-built sites, the receipt of EU GMP certification enables Canopy Growth to continue exporting certified medical cannabis to medical markets in Europe as well as other medical cannabis markets around the world.

Canopy Growth Announces EU GMP Certification of Kincardine Cultivation Facility

Analysts have low expectations for Canopy Growth. Increasing profitability would make it a more appealing purchase on the dip.

Wall Street Sees Canopy Growth Stock Falling 16%. Should You Buy the Dip?

As we enter the second week of October 2023, the US cannabis market is still receiving much attention. With legalization spreading throughout several states, the industry has seen impressive development and financial interest. We'll present you with some of the top US marijuana stocks in this post, which are primed to attract the interest of both traders and investors in the upcoming week. We'll go into the critical elements of using technical indicators and putting good risk management tactics into practice while trading in this dynamic and constantly changing market, in addition to the enthusiasm around these companies.

Top US Marijuana Stocks to Watch in October 2023

Canopy Growth has been divesting its assets and reducing its operations as it looks to cut costs. But with incredibly low gross margins, that may not be a surefire way to get to breakeven.

Where Will Canopy Growth Stock Be in 3 Years?

Investors were encouraged by a peer's latest set of quarterly results. Tilray beat on revenue and narrowed its bottom-line loss.

Why Canopy Growth Stock Skyrocketed Today

Canopy Growth Corporation (TSX:WEED, NYSE:CGC) said on Monday it has completed the previously announced sale of its Hershey Drive facility in Smiths Falls, Ontario, to Hershey Canada Inc, receiving about C$53 million in cash.  The Canadian cannabis firm noted that net proceeds received from the sale will be used primarily to pay down the company's senior secured credit facility.

Canopy Growth receives C$53M from Hershey Drive facility sale

Village Farms International

Investors interested in top Canadian cannabis stocks are in for an exciting trip in October 2023. Despite experiencing its fair share of ups and downs, the Canadian cannabis market is estimated to have a value of $8.5 billion this year, showing consistent growth over the previous few years.

Canadian Cannabis Stocks to Watch in October 2023

Facility sold to Hershey Canada, Inc. for approximately CAD$53 million Canopy Growth completes CAD $155 million of property sales since April 1, 2023 SMITHS FALLS, ON , Oct. 2, 2023 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (Nasdaq: CGC) announced today that it has completed the sale of its Hershey Drive facility (the "Facility") in Smiths Falls, Ontario, in connection with the previously announced agreement with Hershey Canada, Inc. for cash consideration of approximately CAD$53 million. As part of its transformation to a simplified, asset-light operating model, Canopy Growth has sold a total of seven properties for aggregate gross proceeds of approximately CAD$155 million since April 1, 2023.

News for Canopy Growth Stock (CGC)